Larry Denner

4.3k total citations
71 papers, 3.6k citations indexed

About

Larry Denner is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Larry Denner has authored 71 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 12 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Physiology. Recurrent topics in Larry Denner's work include Cell death mechanisms and regulation (9 papers), Neuroscience and Neuropharmacology Research (8 papers) and Alzheimer's disease research and treatments (7 papers). Larry Denner is often cited by papers focused on Cell death mechanisms and regulation (9 papers), Neuroscience and Neuropharmacology Research (8 papers) and Alzheimer's disease research and treatments (7 papers). Larry Denner collaborates with scholars based in United States, Denmark and United Kingdom. Larry Denner's co-authors include Kelly T. Dineley, Nancy L. Weigel, William T. Schrader, Ronald G. Tilton, Bert W. O’Malley, Sigmund J. Haidacher, Marco Marcelli, Lydia Sturgis, Jordan B. Jahrling and Beth Lynn Maxwell and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Larry Denner

71 papers receiving 3.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Larry Denner 1.8k 665 550 524 519 71 3.6k
John S.D. Chan 2.0k 1.1× 271 0.4× 435 0.8× 258 0.5× 1.1k 2.2× 132 4.6k
Eduardo G. Lapetina 2.4k 1.4× 460 0.7× 963 1.8× 540 1.0× 294 0.6× 87 4.4k
Sasanka Ramanadham 2.8k 1.6× 511 0.8× 765 1.4× 256 0.5× 689 1.3× 124 4.6k
Satoshi Ogawa 1.4k 0.8× 171 0.3× 580 1.1× 317 0.6× 287 0.6× 40 3.5k
Toshimasa Onaya 2.3k 1.3× 661 1.0× 726 1.3× 449 0.9× 2.3k 4.4× 209 5.5k
Susan P. LeDoux 3.2k 1.8× 314 0.5× 640 1.2× 195 0.4× 213 0.4× 68 4.6k
Ian R. Sweet 2.1k 1.2× 587 0.9× 777 1.4× 571 1.1× 733 1.4× 85 3.8k
Andrea D. Eckhart 2.7k 1.6× 241 0.4× 513 0.9× 564 1.1× 305 0.6× 66 3.7k
Renu A. Kowluru 3.0k 1.7× 284 0.4× 727 1.3× 148 0.3× 496 1.0× 113 5.5k
Ken L. Chambliss 1.5k 0.9× 1.6k 2.4× 530 1.0× 184 0.4× 992 1.9× 49 3.8k

Countries citing papers authored by Larry Denner

Since Specialization
Citations

This map shows the geographic impact of Larry Denner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Denner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Denner more than expected).

Fields of papers citing papers by Larry Denner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry Denner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Denner. The network helps show where Larry Denner may publish in the future.

Co-authorship network of co-authors of Larry Denner

This figure shows the co-authorship network connecting the top 25 collaborators of Larry Denner. A scholar is included among the top collaborators of Larry Denner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry Denner. Larry Denner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Denner, Larry, et al.. (2019). Divergent Mechanisms for PPARγ Agonism in Ameliorating Aging-Related Versus Cranial Irradiation-Induced Context Discrimination Deficits. Frontiers in Aging Neuroscience. 11. 38–38. 3 indexed citations
2.
Wildburger, Norelle C., Sigmund J. Haidacher, Miroslav N. Nenov, et al.. (2017). PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease. Experimental Neurology. 295. 1–17. 35 indexed citations
3.
Nenov, Miroslav N., Fernanda Laezza, Sigmund J. Haidacher, et al.. (2014). Cognitive Enhancing Treatment with a PPARγ Agonist Normalizes Dentate Granule Cell Presynaptic Function in Tg2576 APP Mice. Journal of Neuroscience. 34(3). 1028–1036. 47 indexed citations
4.
Jahrling, Jordan B., Caterina M. Hernandez, Larry Denner, & Kelly T. Dineley. (2014). PPARγ Recruitment to Active ERK during Memory Consolidation Is Required for Alzheimer's Disease-Related Cognitive Enhancement. Journal of Neuroscience. 34(11). 4054–4063. 59 indexed citations
5.
Petersen, John R., Hyunsu Ju, Luca Cicalese, et al.. (2013). Biomarker Discovery for Early Detection of Hepatocellular Carcinoma in Hepatitis C–infected Patients. Molecular & Cellular Proteomics. 12(12). 3640–3652. 48 indexed citations
6.
Denner, Larry, Jennifer Rodriguez-Rivera, Sigmund J. Haidacher, et al.. (2012). Cognitive Enhancement with Rosiglitazone Links the Hippocampal PPARγ and ERK MAPK Signaling Pathways. Journal of Neuroscience. 32(47). 16725–16735. 100 indexed citations
7.
Bodenburg, Yvonne, et al.. (2012). Development of a novel protocol for isolation and purification of human granulosa cells. Journal of Assisted Reproduction and Genetics. 29(6). 547–556. 22 indexed citations
8.
Im, Dana D., Yingxin Zhao, Heather A. Molenda‐Figueira, et al.. (2010). Steroid receptor coactivator-2 expression in brain and physical associations with steroid receptors. Neuroscience. 169(3). 1017–1028. 26 indexed citations
9.
Rodriguez-Rivera, Jennifer, Larry Denner, & Kelly T. Dineley. (2010). Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status. Behavioural Brain Research. 216(1). 255–261. 75 indexed citations
10.
Nielsen, Jan M., Steen Buus Kristiansen, Rikke Nørregaard, et al.. (2009). Blockage of Receptor for Advanced Glycation End Products Prevents Development of Cardiac Dysfunction in db/db Type 2 Diabetic Mice. European Journal of Heart Failure. 11(7). 638–647. 54 indexed citations
11.
Zhao, Junhan, Yvonne Bodenburg, Colin McGuckin, et al.. (2009). Oct‐4A isoform is expressed in human cord blood‐derived CD133 stem cells and differentiated progeny. Cell Proliferation. 42(3). 265–275. 5 indexed citations
12.
Sriraman, Venkataraman, et al.. (2008). Identification of ERK and JNK as signaling mediators on protein kinase C activation in cultured granulosa cells. Molecular and Cellular Endocrinology. 294(1-2). 52–60. 31 indexed citations
13.
Denner, Larry, Yvonne Bodenburg, Ronald G. Tilton, et al.. (2007). Directed engineering of umbilical cord blood stem cells to produce C‐peptide and insulin. Cell Proliferation. 40(3). 367–380. 54 indexed citations
14.
Denner, Larry, et al.. (2006). Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice. Journal of Endocrinology. 188(3). 493–501. 60 indexed citations
15.
McGuckin, Colin, Nico Forraz, Marc‐Olivier Baradez, et al.. (2005). Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Proliferation. 38(4). 245–255. 149 indexed citations
16.
Dagnæs‐Hansen, Frederik, Lars Melholt Rasmussen, Ronald G. Tilton, Larry Denner, & Allan Flyvbjerg. (2003). A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinoma.. PubMed. 23(2B). 1625–30. 5 indexed citations
17.
Andriani, Francesca, Bin Nan, M Kellis, et al.. (2001). Use of the Probasin Promoter ARR2PB to Express Bax in Androgen Receptor-Positive Prostate Cancer Cells. JNCI Journal of the National Cancer Institute. 93(17). 1314–1324. 33 indexed citations
18.
Marcelli, Marco, Glenn R. Cunningham, Sigmund J. Haidacher, et al.. (1998). Activation of caspase-3 and -7 during apoptosis of the human prostate cancer cell line LNCaP. 39. 577. 1 indexed citations
19.
Cleek, Robert L., Ajay A. Rege, Larry Denner, Suzanne G. Eskin, & Antonios G. Mikos. (1997). Inhibition of smooth muscle cell growthin vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles. Journal of Biomedical Materials Research. 35(4). 525–530. 68 indexed citations
20.
Denner, Larry, William E. Bingman, Geoffrey L. Greene, & Nancy L. Weigel. (1987). Phosphorylation of the chicken progesterone receptor. Journal of Steroid Biochemistry. 27(1-3). 235–243. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John S.D. Chan Breakdown of academic impact, for papers by Eduardo G. Lapetina Breakdown of academic impact, for papers by Sasanka Ramanadham Breakdown of academic impact, for papers by Satoshi Ogawa Breakdown of academic impact, for papers by Toshimasa Onaya Breakdown of academic impact, for papers by Susan P. LeDoux Breakdown of academic impact, for papers by Ian R. Sweet Breakdown of academic impact, for papers by Andrea D. Eckhart Breakdown of academic impact, for papers by Renu A. Kowluru Breakdown of academic impact, for papers by Ken L. Chambliss
Rankless by CCL
2026